Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts

Iwen F. Grigsby; Lan Pham; Raj Gopalakrishnan; Louis M. Mansky; Kim C. Mansky

doi:10.1016/j.bbrc.2009.12.039

Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts

Iwen F. Grigsby, Lan Pham, Raj Gopalakrishnan, Louis M. Mansky, Kim C. Mansky

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

Clinical observations have implicated the antiretroviral drug tenofovir with bone density loss during the management of HIV infection. The goal of this study was to investigate the in vitro effects of tenofovir exposure of primary osteoclasts in order to gain insights into the potential mechanisms for the drug-induced bone density loss. We hypothesized that tenofovir may alter the expression of key genes involved in osteoclast function. To test this, primary osteoclasts were exposed to physiologically relevant concentrations of the prodrug tenofovir disoproxil fumarate (TDF), then intensive microarray analysis was done to compare tenofovir-treated versus untreated cells. Specific downregulation of Gnas, Got2 and Snord32a were observed in the TDF-treated cells. The functions of these genes help to explain the basis for tenofovir-associated bone density loss. Our studies represent the first analysis of the effects of tenofovir on osteoclast gene expression and help to explain the basis of tenofovir-associated bone density loss in HIV-infected individuals.

Original language	English (US)
Pages (from-to)	1324-1329
Number of pages	6
Journal	Biochemical and Biophysical Research Communications
Volume	391
Issue number	3
DOIs	https://doi.org/10.1016/j.bbrc.2009.12.039
State	Published - Jan 15 2010

Bibliographical note

Funding Information:
The following reagent was obtained through the NIH AIDS Research and Reference Reagent program, Division of AIDS, NIAID, NIH: Tenofovir disoproxil fumarate, Catalog No. 10198. We thank Andy Kaplan for stimulating discussions, and David Largaespada and Raha Allaei for assistance with mice. Supported by NIH Grants AR53946 (K.C.M.), DE16093 (R.G.), and GM56615 (L.M.M.). I.F.G. and L.P. were supported by the MinnCResT Program, T32DE07288.

Keywords

AST
G-protein
HAART
HIV
Osteoblast
snoRNA

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.bbrc.2009.12.039

Find It

Find It at U of M Libraries

Cite this

@article{023dbd3ceabc4e868039f50321f80d15,

title = "Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts",

abstract = "Clinical observations have implicated the antiretroviral drug tenofovir with bone density loss during the management of HIV infection. The goal of this study was to investigate the in vitro effects of tenofovir exposure of primary osteoclasts in order to gain insights into the potential mechanisms for the drug-induced bone density loss. We hypothesized that tenofovir may alter the expression of key genes involved in osteoclast function. To test this, primary osteoclasts were exposed to physiologically relevant concentrations of the prodrug tenofovir disoproxil fumarate (TDF), then intensive microarray analysis was done to compare tenofovir-treated versus untreated cells. Specific downregulation of Gnas, Got2 and Snord32a were observed in the TDF-treated cells. The functions of these genes help to explain the basis for tenofovir-associated bone density loss. Our studies represent the first analysis of the effects of tenofovir on osteoclast gene expression and help to explain the basis of tenofovir-associated bone density loss in HIV-infected individuals.",

keywords = "AST, G-protein, HAART, HIV, Osteoblast, snoRNA",

author = "Grigsby, {Iwen F.} and Lan Pham and Raj Gopalakrishnan and Mansky, {Louis M.} and Mansky, {Kim C.}",

note = "Funding Information: The following reagent was obtained through the NIH AIDS Research and Reference Reagent program, Division of AIDS, NIAID, NIH: Tenofovir disoproxil fumarate, Catalog No. 10198. We thank Andy Kaplan for stimulating discussions, and David Largaespada and Raha Allaei for assistance with mice. Supported by NIH Grants AR53946 (K.C.M.), DE16093 (R.G.), and GM56615 (L.M.M.). I.F.G. and L.P. were supported by the MinnCResT Program, T32DE07288.",

year = "2010",

month = jan,

day = "15",

doi = "10.1016/j.bbrc.2009.12.039",

language = "English (US)",

volume = "391",

pages = "1324--1329",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts

AU - Grigsby, Iwen F.

AU - Pham, Lan

AU - Gopalakrishnan, Raj

AU - Mansky, Louis M.

AU - Mansky, Kim C.

N1 - Funding Information: The following reagent was obtained through the NIH AIDS Research and Reference Reagent program, Division of AIDS, NIAID, NIH: Tenofovir disoproxil fumarate, Catalog No. 10198. We thank Andy Kaplan for stimulating discussions, and David Largaespada and Raha Allaei for assistance with mice. Supported by NIH Grants AR53946 (K.C.M.), DE16093 (R.G.), and GM56615 (L.M.M.). I.F.G. and L.P. were supported by the MinnCResT Program, T32DE07288.

PY - 2010/1/15

Y1 - 2010/1/15

N2 - Clinical observations have implicated the antiretroviral drug tenofovir with bone density loss during the management of HIV infection. The goal of this study was to investigate the in vitro effects of tenofovir exposure of primary osteoclasts in order to gain insights into the potential mechanisms for the drug-induced bone density loss. We hypothesized that tenofovir may alter the expression of key genes involved in osteoclast function. To test this, primary osteoclasts were exposed to physiologically relevant concentrations of the prodrug tenofovir disoproxil fumarate (TDF), then intensive microarray analysis was done to compare tenofovir-treated versus untreated cells. Specific downregulation of Gnas, Got2 and Snord32a were observed in the TDF-treated cells. The functions of these genes help to explain the basis for tenofovir-associated bone density loss. Our studies represent the first analysis of the effects of tenofovir on osteoclast gene expression and help to explain the basis of tenofovir-associated bone density loss in HIV-infected individuals.

AB - Clinical observations have implicated the antiretroviral drug tenofovir with bone density loss during the management of HIV infection. The goal of this study was to investigate the in vitro effects of tenofovir exposure of primary osteoclasts in order to gain insights into the potential mechanisms for the drug-induced bone density loss. We hypothesized that tenofovir may alter the expression of key genes involved in osteoclast function. To test this, primary osteoclasts were exposed to physiologically relevant concentrations of the prodrug tenofovir disoproxil fumarate (TDF), then intensive microarray analysis was done to compare tenofovir-treated versus untreated cells. Specific downregulation of Gnas, Got2 and Snord32a were observed in the TDF-treated cells. The functions of these genes help to explain the basis for tenofovir-associated bone density loss. Our studies represent the first analysis of the effects of tenofovir on osteoclast gene expression and help to explain the basis of tenofovir-associated bone density loss in HIV-infected individuals.

KW - AST

KW - G-protein

KW - HAART

KW - HIV

KW - Osteoblast

KW - snoRNA

UR - http://www.scopus.com/inward/record.url?scp=73949105375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949105375&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.12.039

DO - 10.1016/j.bbrc.2009.12.039

M3 - Article

C2 - 20026012

AN - SCOPUS:73949105375

SN - 0006-291X

VL - 391

SP - 1324

EP - 1329

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

IS - 3

ER -

Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this